Arla's Whey Protein Hydrolysates FDA Cleared for Inclusion in Infant Formula
Saturday, 13 July 2024, 13:52
Arla's Whey Protein Hydrolysates FDA Approval
The Food and Drug Administration has cleared Arla's whey protein hydrolysates for use in infant formula, marking a key milestone for the company.
Significance in Infant Nutrition Market
This FDA approval signifies the safety and effectiveness of Arla's whey protein hydrolysates, positioning the company for growth in the infant nutrition sector.
- Innovation: Arla's product innovation and commitment to quality are highlighted by this clearance.
- Regulatory Compliance: The FDA approval underscores Arla's adherence to stringent regulatory standards.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.